Literature DB >> 2734732

Modified forms of low density lipoprotein affect platelet aggregation in vitro.

M Aviram1.   

Abstract

Modified forms of low density lipoprotein (LDL) unlike native LDL can lead to macrophage cholesterol accumulation and foam cell formation. Since platelets interact with both lipoprotein and macrophages in the atherosclerotic plaque, the present study was designed to analyze the effect of modified LDL on washed human platelet composition and aggregation. Platelet aggregation was increased following 2 h of incubation with native LDL. Phospholipase C modified LDL and hepatic lipase modified LDL but not acetyl LDL further increased collagen induced platelet aggregation in a dose dependent manner by up to 15% (p less than 0.01). Oxidized LDL, however, demonstrated 25% reduction in both collagen and ADP induced platelet aggregation in comparison to the effect of native LDL. Platelet aggregation was found to be directly related to changes in platelet phospholipid content whereas platelet cholesterol content was similarly affected by all lipoproteins. Platelet cholesterol/phospholipid ratio was directly related to platelet aggregation. Our study thus demonstrates that modified forms of LDL significantly affect platelet lipid composition and function and if similar interactions occur in vivo it might also affect the atherogenic process.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2734732     DOI: 10.1016/0049-3848(89)90145-x

Source DB:  PubMed          Journal:  Thromb Res        ISSN: 0049-3848            Impact factor:   3.944


  7 in total

Review 1.  Did the antioxidant trials fail to validate the oxidation hypothesis?

Authors:  S Parthasarathy; N Khan-Merchant; M Penumetcha; B V Khan; N Santanam
Journal:  Curr Atheroscler Rep       Date:  2001-09       Impact factor: 5.113

Review 2.  Role of oxidized low density lipoprotein in atherogenesis.

Authors:  J L Witztum; D Steinberg
Journal:  J Clin Invest       Date:  1991-12       Impact factor: 14.808

3.  Decreased adhesion of oxidized LDL-stimulated platelets caused by cytochalasin D.

Authors:  B Zhao; T J Filler; C H Rickert; R Dierichs
Journal:  Cell Tissue Res       Date:  1995-04       Impact factor: 5.249

4.  Oxidized LDL inhibits vascular endothelial cell morphogenesis in culture.

Authors:  D Y Wang; V C Yang; J K Chen
Journal:  In Vitro Cell Dev Biol Anim       Date:  1997-04       Impact factor: 2.723

5.  Oxidative susceptibility of low density lipoprotein subfractions is related to their ubiquinol-10 and alpha-tocopherol content.

Authors:  D L Tribble; J J van den Berg; P A Motchnik; B N Ames; D M Lewis; A Chait; R M Krauss
Journal:  Proc Natl Acad Sci U S A       Date:  1994-02-01       Impact factor: 11.205

6.  The actions of lovastatin on platelet function and platelet eicosanoid receptors in type II hypercholesterolaemia. A double-blind, placebo-controlled, prospective study.

Authors:  D Kaczmarek; T Hohlfeld; G Wambach; K Schrör
Journal:  Eur J Clin Pharmacol       Date:  1993       Impact factor: 2.953

7.  Oxidized LDL activates blood platelets through CD36/NOX2-mediated inhibition of the cGMP/protein kinase G signaling cascade.

Authors:  Simbarashe Magwenzi; Casey Woodward; Katie S Wraith; Ahmed Aburima; Zaher Raslan; Huw Jones; Catriona McNeil; Stephen Wheatcroft; Nadira Yuldasheva; Maria Febbriao; Mark Kearney; Khalid M Naseem
Journal:  Blood       Date:  2015-02-20       Impact factor: 22.113

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.